AgeX Therapeutics to Present at Investing in the Age of Longevity Conference

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that the company will present at Investing in the Age of Longevity, organized by Master Investor, Ltd., on Wednesday, November 13 at Science Gallery London. Details of the company’s participation: 10:45am GMT, Science Track: A presentation on AgeX’s induced Tissue Regeneration (iTRTM) product developm

Click to view original post